Choline and betaine intake and colorectal cancer risk in Chinese population: a case-control study

PloS One
Min-Shan LuCai-Xia Zhang

Abstract

Few studies have examined the association of choline and betaine intake with colorectal cancer risk, although they might play an important role in colorectal cancer development because of their role as methyl donors. The aim of this study was to examine the relationship between consumption of choline and betaine and colorectal cancer risk in a Chinese population. A case-control study was conducted between July 2010 and December 2013 in Guangzhou, China. Eight hundred and ninety consecutively recruited colorectal cancer cases were frequency matched to 890 controls by age (5-year interval) and sex. Dietary information was assessed with a validated food frequency questionnaire by face-to-face interviews. The logistic regression model was used to estimate multivariate odds ratios (ORs) and 95% confidence intervals (CIs). Total choline intake was inversely associated with colorectal cancer risk after adjustment for various lifestyle and dietary factors. The multivariate-adjusted OR was 0.54 (95%CI = 0.37-0.80, Ptrend <0.01) comparing the highest with the lowest quartile. No significant associations were observed for betaine or total choline+betaine intakes. For choline-containing compounds, lower colorectal cancer risk was associate...Continue Reading

References

Jan 1, 1994·Human Molecular Genetics·P W Laird, R Jaenisch
Jan 1, 1994·Annual Review of Nutrition·S H Zeisel, J K Blusztajn
May 18, 1994·Journal of the National Cancer Institute·S Rainier, A P Feinberg
Apr 1, 1997·The American Journal of Clinical Nutrition·W C WillettL H Kushi
Mar 20, 1999·The Journal of Nutrition·R A JacobM E Swendseid
May 6, 2003·The Journal of Nutrition·Steven H ZeiselJoanne M Holden
Dec 24, 2005·Journal of the American College of Nutrition·Kaoru KusamaShigeru Yamamoto
May 25, 2006·Journal of Agricultural and Food Chemistry·Xianli WuRonald L Prior
Aug 10, 2007·Journal of the National Cancer Institute·Eunyoung ChoEdward L Giovannucci
Dec 19, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Eunyoung ChoWalter C Willett
Jan 31, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Xinran XuJia Chen
Aug 27, 2009·European Journal of Clinical Nutrition·J KotsopoulosS S Tworoger
Nov 13, 2009·Nutrition Reviews·Steven H Zeisel, Kerry-Ann da Costa
Jan 7, 2010·British Journal of Cancer·E ChoW C Willett
Feb 18, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jung Eun LeeEunyoung Cho
Jul 29, 2010·Expert Reviews in Molecular Medicine·Yutaka Kondo, Jean-Pierre J Issa
Jan 29, 2011·The American Journal of Clinical Nutrition·Jung Eun LeeEdward Giovannucci
Sep 7, 2012·The American Journal of Clinical Nutrition·Erin L RichmanJune M Chan
Sep 22, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Mohmmad HaidariFarid Najaf
Feb 5, 2013·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Xiao ZhongCai-Xia Zhang

❮ Previous
Next ❯

Citations

Mar 16, 2018·Metabolomics : Official Journal of the Metabolomic Society·Hailong ZhangHuijuan Wang
Dec 24, 2018·American Journal of Physiology. Gastrointestinal and Liver Physiology·Åke Nilsson, Rui-Dong Duan
Jun 9, 2018·Frontiers in Immunology·Guangfu ZhaoYuanyi Peng
Mar 16, 2019·Nutrients·Abeer M Mahmoud, Mohamed M Ali
Nov 22, 2019·Cancer Prevention Research·Matthew P HanleyDaniel W Rosenberg

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics and Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Related Papers

European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
Xiao ZhongCai-Xia Zhang
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
Cai-Xia ZhangJian-Hua Fu
© 2021 Meta ULC. All rights reserved